Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Alzchem Group AG's average EBITDA Per Share Growth Rate was 13.10% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 19.80% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 17.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Alzchem Group AG was 19.80% per year. The lowest was -72.70% per year. And the median was 9.85% per year.
Alzchem Group AG (XTER:ACT) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Alzchem Group AG 5-Year EBITDA Growth Rate Related Terms
XTER:ACT vs LIN, SHW, ECL: 5-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Alzchem Group AG's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alzchem Group AG 5-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Alzchem Group AG's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Alzchem Group AG's 5-Year EBITDA Growth Rate falls into.
Alzchem Group AG 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of 17.90% mean?
Alzchem Group AG (XTER:ACT) has a 5-Year EBITDA Growth Rate of 17.90% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Alzchem Group AG and its competitors.
Is Alzchem Group AG's 5-Year EBITDA Growth Rate too high?
Alzchem Group AG's current 5-Year EBITDA Growth Rate is 17.90%. Overall, Alzchem Group AG has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's 5-Year EBITDA Growth Rate compare to LIN and SHW?
Alzchem Group AG's 5-Year EBITDA Growth Rate of 17.90% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Chemicals company?
A good 5-Year EBITDA Growth Rate depends on the Chemicals industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Alzchem Group AG and its competitors. Alzchem Group AG's current 5-Year EBITDA Growth Rate is 17.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (XTER:ACT) has a current 5-Year EBITDA Growth Rate of 17.90%. The current 5-Year EBITDA Growth Rate is 17.90%. Alzchem Group AG's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Alzchem Group AG (XTER:ACT), the current 5-Year EBITDA Growth Rate is 17.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
60GF Score
Get the complete analysis for XTER:ACT
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:ACT has been successfully added to your 
